The results of our study are quite different from those presented in existing literature 9, which represent that there may be significant differences in the expression and function of PLD2 in CRC cells among persons of different races, or it may be due to the differences in experimental systems and antibodies used. The gene discussed is PLD2; the disease is colorectal carcinoma.